Sonendo Inc Quick Ratio (SONX) starting from the fourth quarter 2024 to fourth quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Sonendo Inc   (SONX)

Sonendo Inc 's Quick Ratio

SONX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2024, Quick Ratio fell to 0.58 a new company low.

Within Medical Equipment & Supplies industry 136 other companies have achieved higher Quick Ratio than Sonendo Inc in fourth quarter 2024. While Quick Ratio total ranking in the fourth quarter 2024 has deteriorated compared to the prior quarter from 1233 to 2306.

Explain Quick Ratio?
How much Cash & cash equivalents SONX´s has?
What are SONX´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SONX Quick Ratio (Dec 31 2024)
Q4		 (Sep 30 2024)
Q3		 (Jun 30 2024)
Q2		 (Mar 31 2024)
Q1		 (Dec 31 2023)
Q4
Y / Y Current Liabilities Change -36.06 % 360.05 % 259.61 % 60.66 % 264.36 %
Y / Y Cash & cash equivalent Change -75.15 % -69.1 % -63.22 % -55.18 % -48.84 %
Quick Ratio MRQ 0.58 0.9 1.43 2.3 1.5
SONX's Total Ranking # 2306 # 1233 # 1304 # 1137 # 1366
Seq. Current Liabilities Change 4.31 % 12.88 % 15.85 % -53.13 % 650.57 %
Seq. Cash & cash equivalent Change -32.73 % -28.68 % -27.85 % -28.2 % -16.37 %



Quick Ratio fourth quarter 2024 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 137
Healthcare Sector # 737
Overall Market # 2306


Quick Ratio Statistics
High Average Low
7.9 3.91 0.58
(Sep 30 2022)   (Dec 31 2024)




Financial Statements
Sonendo Inc 's Current Liabilities $ 20 Millions Visit SONX's Balance sheet
Sonendo Inc 's Cash & cash equivalent $ 12 Millions Visit SONX's Balance sheet
Source of SONX's Sales Visit SONX's Sales by Geography


Cumulative Sonendo Inc 's Quick Ratio

SONX's Quick Ratio for the trailling 12 Months

SONX Quick Ratio

 (Dec 31 2024)
12 Months		 (Sep 30 2024)
12 Months		 (Jun 30 2024)
12 Months		 (Mar 31 2024)
12 Months		 (Dec 31 2023)
12 Months
Y / Y Current Liabilities TTM Growth 43.66 % 208.63 % 135.7 % 84.34 % 86.41 %
Y / Y Cash & cash equivalent TTM Growth -64.39 % -57.71 % -52.48 % -37.55 % -22.66 %
Quick Ratio TTM 1.23 1.49 2.4 3.7 4.96
Total Ranking TTM # 3671 # 3339 # 3286 # 3242 # 3199
Seq. Current Liabilities TTM Growth -13.74 % 22.36 % 22.36 % 11.23 % 85.32 %
Seq. Cash & cash equivalent TTM Growth -28.84 % -24.08 % -20.6 % -16.98 % -15.5 %

Quick ratio ranking by company, industry and sector >> Back to SONX Financial Strength Comparisons >> Go to Compare SONX Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in SONX's Current Liabilities to $19.94 millions, cumulative Quick Ratio to 1.23 below the SONX average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 209 other companies have achieved higher Quick Ratio than Sonendo Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2024 from 3339 to 3671.

Explain Quick Ratio?
How much Cash & cash equivalents SONX´s has?
What are SONX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 210
Healthcare Sector # 941
Within the Market # 3671


trailing twelve months Quick Ratio Statistics
High Average Low
5.86 3.74 1.15
(Jun 30 2023)   (Dec 31 2024)




Companies with similar Quick Ratio in the quarter ending Dec 31 2024, within Medical Equipment & Supplies Industry Quick RatioDec 31 2024 MRQ Cash & cash equivalentDec 31 2024 MRQ Current Liabilities
Semler Scientific inc   1.59 $ 8.819  Millions$ 5.539  Millions
Nyxoah Sa  1.59 $ 38.288  Millions$ 24.113  Millions
Neuraxis Inc   1.57 $ 3.717  Millions$ 2.361  Millions
Carlisle Companies Incorporated  1.50 $ 753.500  Millions$ 502.700  Millions
Lensar Inc   1.50 $ 22.455  Millions$ 15.003  Millions
Heartbeam Inc   1.47 $ 2.377  Millions$ 1.622  Millions
Novocure Limited  1.45 $ 959.873  Millions$ 663.246  Millions
Catheter Precision Inc   1.38 $ 2.873  Millions$ 2.085  Millions
Electrocore Inc   1.36 $ 11.969  Millions$ 8.791  Millions
Si bone inc   1.35 $ 34.948  Millions$ 25.980  Millions
Meihua International Medical Technologies Co Ltd  1.34 $ 33.249  Millions$ 24.765  Millions
Koru Medical Systems Inc   1.33 $ 9.581  Millions$ 7.202  Millions
Establishment Labs Holdings Inc   1.32 $ 90.347  Millions$ 68.278  Millions
Polypid Ltd  1.32 $ 15.809  Millions$ 11.970  Millions
Cerus Corporation  1.26 $ 80.452  Millions$ 63.608  Millions
Vivos Therapeutics Inc   1.26 $ 6.260  Millions$ 4.978  Millions
Envista Holdings Corporation  1.22 $ 1,069.100  Millions$ 878.700  Millions
Axogen inc   1.17 $ 33.482  Millions$ 28.641  Millions
Lifeward ltd   1.17 $ 13.492  Millions$ 11.549  Millions
Intelligent Bio Solutions Inc   1.16 $ 6.304  Millions$ 5.451  Millions
Acutus Medical Inc   1.13 $ 14.019  Millions$ 12.438  Millions
Privia Health Group Inc   1.00 $ 491.149  Millions$ 492.404  Millions
West Pharmaceutical Services Inc   0.88 $ 484.600  Millions$ 550.400  Millions
Milestone Scientific Inc   0.87 $ 3.258  Millions$ 3.744  Millions
Lucid Diagnostics Inc   0.85 $ 22.358  Millions$ 26.353  Millions
Stryker Corp  0.84 $ 4,540.000  Millions$ 5,379.000  Millions
Sonoma Pharmaceuticals Inc   0.84 $ 3.128  Millions$ 3.719  Millions
Angiodynamics Inc   0.83 $ 76.056  Millions$ 91.155  Millions
Trisalus Life Sciences Inc   0.83 $ 8.525  Millions$ 10.228  Millions
Allurion Technologies Inc   0.82 $ 15.379  Millions$ 18.863  Millions

Date modified: 2026-08-29T07:24:50+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.